Live Stock Coverage: Is Chemours Co’s Fuel Running Low? The Stock Reaches All Time High Today

Live Stock Coverage: Is Chemours Co's Fuel Running Low? The Stock Reaches All Time High Today

The stock of Chemours Co (NYSE:CC) reached all time high today, Nov, 7 and still has $32.45 target or 67.00% above today’s $19.43 share price. This indicates more upside for the $3.49 billion company. This technical setup was reported by Barchart.com. If the $32.45 PT is reached, the company will be worth $2.34 billion more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events. About 3.15M shares traded hands or 45.16% up from the average. Chemours Co (NYSE:CC) has risen 139.83% since April 5, 2016 and is uptrending. It has outperformed by 137.88% the S&P500.

Chemours Co (NYSE:CC) Ratings Coverage

Out of 8 analysts covering Chemours (NYSE:CC), 3 rate it a “Buy”, 1 “Sell”, while 4 “Hold”. This means 38% are positive. Chemours has been the topic of 16 analyst reports since July 27, 2015 according to StockzIntelligence Inc. Susquehanna initiated it with “Neutral” rating and $13 target price in Monday, July 27 report. The rating was upgraded by Argus Research on Wednesday, August 10 to “Buy”. Citigroup maintained the stock with “Neutral” rating in Thursday, August 11 report. The stock of Chemours Co (NYSE:CC) has “Sell” rating given on Tuesday, August 18 by UBS. The firm has “Underweight” rating given on Friday, August 7 by JP Morgan. The firm has “Hold” rating by Jefferies given on Tuesday, February 16. As per Friday, September 18, the company rating was initiated by Argus Research. On Thursday, September 1 the stock rating was maintained by Jefferies with “Hold”. Goldman Sachs upgraded the stock to “Buy” rating in Monday, March 14 report. The stock has “Sell” rating given by UBS on Tuesday, August 9.

According to Zacks Investment Research, “Chemours Company is involved in chemical business. It operating segment consists of Titanium Technologies, Fluoroproducts and Chemical Solutions. Titanium Technologies segment produces titanium dioxide and premium white pigment. Fluoroproducts segment provides fluoroproducts, refrigerants and industrial fluoropolymer resins. Chemical Solutions segment provides industrial and specialty chemicals. The company’s brand consists of Teflon(R), Ti-Pure(R), Krytox(R) Viton(R), Opteon(R) and Nafion(R). Chemours Company is headquartered in Wilmington.”

More notable recent Chemours Co (NYSE:CC) news were published by: Investorplace.com which released: “Trade of the Day: Chemours Co (NYSE:CC)” on October 26, 2016, also Fool.com with their article: “Chemours Co Surges After New Jury Verdict” published on July 08, 2016, Valuewalk.com published: “Chemours Co (CC) “Most Morally And Financially Bankrupt Company” Ever: Citron …” on June 02, 2016. More interesting news about Chemours Co (NYSE:CC) were released by: Valuewalk.com and their article: “Chemours Co (CC) Starts To Rally After Tanking On Wednesday” published on July 07, 2016 as well as Fool.com‘s news article titled: “Here’s Why Chemours Co Stock Popped Today” with publication date: February 24, 2016.

CC Company Profile

The Chemours Company, incorporated on February 18, 2014, is a well-known provider of performance chemicals. The Firm operates through three divisions: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Company’s Titanium Technologies segment produces titanium dioxide (TiO2). The Company’s Fluoroproducts segment provides fluoroproducts, such as refrigerants and industrial fluoropolymer resins. The Company’s Chemical Solutions segment provides industrial and specialty chemicals used in gold production, oil refining, agriculture, industrial polymers and other industries. The Firm operates approximately 30 production facilities located in over 10 countries and serves a range of end markets in over 130 countries.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment